fda warning letters compounded semaglutide tirzepatide september 2025 A company called Nomida has received an letter for offering for sale injectable weight-loss treatments. None of their offerings are FDA-approved. Nomida is allegedly selling unapproved and "kits" FDA Issues Warning Letters to

Extended follow-up durations are recommended to evaluate the sustainability of therapeutic effects and monitor for delayed outcomes

faecalis is extremely similar to fungal BDG, as the clinical BDG test for diagnosing IFIs has false positives in patients with colonization and/or infection with this bacterium ( Beyond mycoses, BDG has been shown to induce long-term epigenetic reprogramming, reverse LPS-induced tolerization in monocytes/macrophages, and confer protection from infectious diseases including leishmaniasis and tuberculosis (44)

Bork, vice president of intellectual property at Novo Nordisk

Understanding GLP-1 Dosing Schedules When we talk about GLP-1 receptor agonists, we are referring to a class of medications that mimic a hormone naturally produced in your gut

Brand-name Zepbound similarly carries significant out-of-pocket costs without coverage

Consulting with healthcare professionals and considering alternative approved treatments like Wegovy can provide safer and more structured weight management solutions